![PDF] No benefit from combining HE4 and CA125 as ovarian tumor markers in a clinical setting. | Semantic Scholar PDF] No benefit from combining HE4 and CA125 as ovarian tumor markers in a clinical setting. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/7968dca1873e681e0be5dd4a14690d730da0e0b2/4-Table1-1.png)
PDF] No benefit from combining HE4 and CA125 as ovarian tumor markers in a clinical setting. | Semantic Scholar
![Risk of ovarian cancer in women with symptoms in primary care: population based case-control study | The BMJ Risk of ovarian cancer in women with symptoms in primary care: population based case-control study | The BMJ](https://www.bmj.com/content/bmj/339/bmj.b2998/F2.large.jpg)
Risk of ovarian cancer in women with symptoms in primary care: population based case-control study | The BMJ
Performance of preoperative plasma tumor markers HE4 and CA125 in predicting ovarian cancer mortality in women with epithelial ovarian cancer | PLOS ONE
![Past, Present, and Future of Serum Tumor Markers in Management of Ovarian Cancer: A Guide for the Radiologist | RadioGraphics Past, Present, and Future of Serum Tumor Markers in Management of Ovarian Cancer: A Guide for the Radiologist | RadioGraphics](https://pubs.rsna.org/cms/10.1148/rg.2021210005/asset/images/medium/rg.2021210005.va.gif)
Past, Present, and Future of Serum Tumor Markers in Management of Ovarian Cancer: A Guide for the Radiologist | RadioGraphics
![USMLE Mnemonics by Raza on Twitter: "Tumor markers #usmle #MedTwitter #MedEd #razausmlemnemonics https://t.co/NOMEuzz6IU" / Twitter USMLE Mnemonics by Raza on Twitter: "Tumor markers #usmle #MedTwitter #MedEd #razausmlemnemonics https://t.co/NOMEuzz6IU" / Twitter](https://pbs.twimg.com/media/FRN-VXMWYAAhefW.jpg)